Hospital
City of Jackson Healthcare Authority
City of Jackson Healthcare Authority was paid $2.48M by Medicaid between Jan 2018 and Dec 2024, across 82 billing codes. Its largest line is 99285, emergency room visit (most serious) — 28% of everything it billed.
33Billing provider infoCITY OF JACKSON HEALTHCARE AUTHORITY
JACKSON, AL 36545
JACKSON, AL 36545
33aNPI1952427874assigned 03/22/2007
33bProvider typeRural Acute Care Hospital
28Total paid$2.48M
24GClaims81,853
24DCodes billed82
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Rural Acute Care Hospital providers in Alabama
Rank by total paid#3 of 11
Median peer was paid$1.34M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,412 | $347K | |
| 2019 | 15,151 | $388K | |
| 2020 | 8,600 | $244K | |
| 2021 | 11,375 | $367K | |
| 2022 | 11,917 | $449K | |
| 2023 | 11,513 | $428K | |
| 2024incomplete | 7,885 | $259K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 28% | 4,430 | 3,019 | $682K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 23% | 11,309 | 9,584 | $566K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 11,226 | 6,831 | $346K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.3% | 6,802 | 5,979 | $230K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.5% | 4,091 | 2,955 | $211K |
| 87631 | 4.2% | 1,424 | 1,328 | $105K | |
| 87428 | 1.5% | 894 | 804 | $37K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 653 | 598 | $34K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.4% | 6,088 | 4,892 | $34K |
| 80053 | Comprehensive metabolic panel | 1.2% | 3,649 | 2,948 | $30K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 4,205 | 3,365 | $28K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 875 | 687 | $24K |
70 more codes
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 909 | $18K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 183 | $15K |
| 87276 | <1% | 1,137 | $14K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 1,618 | $11K |
| 87275 | <1% | 1,137 | $10K | |
| 80061 | Lipid panel | <1% | 451 | $6K |
| 80050 | General health panel | <1% | 137 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 443 | $5K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 606 | $5K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 545 | $4K |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 1,444 | $4K |
| 81001 | <1% | 1,279 | $4K | |
| 82553 | <1% | 402 | $3K | |
| 86317 | <1% | 313 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 40 | $3K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,102 | $3K |
| 84484 | <1% | 438 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 84 | $2K |
| 82550 | <1% | 503 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 220 | $2K |
| 87147 | <1% | 856 | $2K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 73 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 212 | $2K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 509 | $2K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 47 | $2K |
| 84439 | <1% | 223 | $2K | |
| 82948 | <1% | 843 | $2K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 54 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 46 | $2K |
| 81025 | <1% | 410 | $975.80 | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 15 | $953.40 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 20 | $910.00 |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 12 | $836.36 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 99 | $792.71 |
| 80306 | <1% | 93 | $782.32 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 48 | $650.65 |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 25 | $615.16 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 77 | $604.17 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,982 | $593.68 |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 25 | $579.40 |
| 83690 | <1% | 92 | $557.52 | |
| 83880 | <1% | 34 | $481.91 | |
| 85610 | <1% | 143 | $426.98 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 20 | $414.00 |
| 90656 | <1% | 56 | $392.62 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,463 | $368.03 |
| 0012A | <1% | 15 | $345.51 | |
| 82150 | <1% | 60 | $330.87 | |
| 83735 | <1% | 62 | $279.68 | |
| 71045 | Radiologic examination, chest; single view | <1% | 102 | $237.80 |
| 82043 | <1% | 35 | $154.17 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 137 | $150.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 14 | $134.80 |
| 99000 | <1% | 869 | $123.31 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 16 | $82.21 |
| 85730 | <1% | 66 | $61.32 | |
| 81002 | <1% | 45 | $56.61 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 150 | $48.48 |
| 85027 | <1% | 12 | $42.96 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 17 | $34.81 |
| 36415 | Collection of venous blood by venipuncture | <1% | 420 | $2.24 |
| 0240U | 0% | 13 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 187 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 14 | $0.00 |
| 82962 | 0% | 16 | $0.00 | |
| 3074F | 0% | 63 | $0.00 | |
| 1159F | 0% | 151 | $0.00 | |
| 3078F | 0% | 98 | $0.00 | |
| 1160F | 0% | 151 | $0.00 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRYLAND, JENNIFER (CEO)